diagnosis and treatment of chronic neurodegenerative diseases and forms of dementia, including Alzheimer’s Disease. (B) The ability to attract the participation of scientists who are capable of ingenuity and creativity in health-care research efforts. (C) An advisory committee composed of veterans and appropriate health-care and research representatives of the Department health-care facility and of the affiliated school or schools to advise the directors of such facility and such center on policy matters pertaining to the activities of the center during the period of the operation of such center. (D) The capability to conduct effectively evaluations of the activities of such center. (E) The capability to coordinate (as part of an integrated national system) education, clinical, and research activities within all facilities with such centers. (F) The capability to jointly develop a consortium of providers with interest in treating Alzheimer’s Disease and other forms of dementia, at facilities without centers established under subsection (a) in order to ensure better access to state-of-the-art diagnosis, care, and education for neu­ro­de­gen­er­a­tive disorders throughout the health-care system of the Department. (G) The capability to develop a national repository in the health-care system of the Department for the collection of data on health services delivered to veterans seeking care for neurodegenerative diseases, including Alzheimer’s Disease and dementia. (H) A scientific specialization in a field of research likely to be transformative to the development of a cure or treatment for Alzheimer’s Disease, including the capability to study the connection between Alzheimer’s Disease and Down Syndrome. (c) Peer review panel (1) The Under Secretary for Health shall establish a panel to assess the scientific and clinical merit of proposals that are submitted to the Secretary for the establishment of centers under this section. (2) (A) The membership of the panel shall consist of experts in neurodegenerative